National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

HspE7
A recombinant chimeric protein composed of the heat shock protein 65 (Hsp65) from Mycobacterium bovis, and the human papilloma viral (HPV) protein E7. Hsp65, similar to other members of its family of proteins, elicits a strong immune response and may be used to design vaccines against a number of different cancers. E7 protein is involved in carcinogenesis of anal and cervical tumors, and represents a tumor antigen that may be specifically targeted by lymphocytes. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:HPV 16 E7/HSP65 Vaccine
HPV E7 Peptide Epitope Vaccine
Code name:SGN-00101



Previous:Hsp90 antagonist KW-2478, Hsp90 inhibitor AUY922, Hsp90 inhibitor BIIB028, Hsp90 inhibitor SNX-5422 mesylate, Hsp90 inhibitor STA-9090
Next:HSV-TK-transduced donor lymphocytes, hTERT I540/R572Y/D988Y multipeptide vaccine, hu14.18-IL2 fusion protein, huBC1-huIL12 fusion protein AS1409, HuC242-DM4

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov